Aptamer functionalized nanostructured biosensing platforms for enteric pathogenic bacteria
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
IISERM
Abstract
Out of the vast myriad of bacterial species that colonize the gastrointestinal tract, Escherichia coli has been a
persistent member of the mammalian gut microflora where a majority of its strains maintain a commensal or
mutualistic relationship with the human host 1 . However, its disease-causing variants (pathogens) genetically
encoded with specific virulence factors also exist 2,3 . Pathogenic E. coli has been reported as a significant
etiological agent of bacterial gastroenteritis with an infectious dose as low as ~100 cells 4,5 . These are responsible
for chronic or persistent diarrhea, with certain pathotypes producing enterotoxins responsible for the hemolytic
uremic syndrome as sequela 6–8 . Conventional ‘gold standard’ microbiological tools require 2-3 days for
identification, while the current diagnostic approaches majorly reliant on antibody-based assays or mass
spectrometry, utilize costly reagents and require specific instrumentations for estimation 9,1011 . Thus, the
challenge lies in developing sensitive, rapid, non-culture dependent, and cost-effective methodologies for the
sensing of enteric pathogenic bacteria, which are required for timely monitoring in food, clinical, and municipal
sectors.
Integrated biosensing platforms with specific bio-receptor (nucleic acid aptamers) and sensitive
transducer (nanostructured materials), providing near real-time information on the presence of enteric targets,
are proposed in this doctoral thesis. Nanostructures of various dimensions based on carbon, metal-carbon
nanohybrids, and more recently, its 2D analogs transition metal chalcogenides, harboring fascinating electronic,
optoelectronic, and physical qualities such as abundant surface charges, high surface-to-volume ratio, and easy
functionalization abilities were synthesized indigenously via various top-down and bottom-up approaches and
utilized as transducers in the biosensing platforms. Simultaneously, for the bio-receptor component,
deoxynucleic acid (DNA) aptamers (single-stranded oligomers with high binding affinity with the specific
target) were chosen, providing low cross-reactivity than conventionally available counterparts 12,13 . The studies
reported in this thesis majorly gravitate around biosensing pathogenic E. coli (serotypes O78:H11 and O157:H7)
with aptamer-based nanostructured sensing technology as the critical line of detection approach.
We devised a three-way approach for aptamer generation stemming from alternative enhanced binding
affinities for the target in various environments, which was based on the hypothesis that the presence of both
whole-cell or its components is possible for monitoring the bacterial targets. Therefore, multiple respective
aptamers were screened against the avirulent strains of whole-cell E. coli (enterotoxigenic serotype O78:H11
and enterohemorrhagic serotype O157:H7), surface antigens (endotoxin, flagellar protein) for serotype
O157:H7, and Shiga-like toxins (Stx1 and Stx2) utilized as bio-recognition moieties, which are
comprehensively explored one-by-one during the doctoral studies. The objective was also to explore
methodologies for aptamer generation and the simultaneous synthesis of nanostructures relevant for aptasensing
via spectroscopic and electrochemical tools. Thus, in line with our aim, various fully characterized DNA
aptamers with an excellent affinity (nanomolar K d ) to the selected bacterial targets were successfully screened
ifrom a naïve oligomer library of 81 nucleotides with 45 nucleotide random region, implementing indigenous
in-vitro selection SELEX (systematic evolution of ligands by exponential enrichment) methodologies of
oligomer panning for the selected targets:
(i)
Microtiter cell-SELEX using phenylboronic acid as a capturing agent for E. coli bacteria accompanied
by counter screening to mitigate aptamer cross-talk with other closely related bacterial species (K d of 14 nM for
O78:H11 and 69 nM for O157:H7 serotype, respectively) was developed.
(ii)
Competitive microtiter-SELEX employing rival ligands for raising stringency for purified E. coli
O157:H7 endotoxin and flagellar proteins (K d of 5.3 and 4.6 nM, respectively) was developed.
(iii)
Biolayer interferometry (BLI)-SELEX using Octet Red96 system, a one-step technique for rapidly
generating aptamers against E. coli Shiga toxin subtypes viz., Stx1 & Stx2 via specific epitopic peptides (K d of
47 pM & 29 pM, respectively) in a dip microtiter plate format, obliterating the need for multiple oligomer
enrichment cycles was designed and demonstrated.
Parallelly, novel nanomaterials of various nano-dimensions (0D, 1D, 2D, 3D) exhibiting excellent
transducer properties were synthesized and characterized using microscopic (scanning electron microscopy,
transmission electron microscopy), spectroscopic (ultraviolet-visible and fluorescence spectroscopy, confocal
Raman spectroscopy, Fourier transform Infra-red spectroscopy, X-ray diffraction and, energy-dispersive X-ray
elemental mapping), electrochemical (cyclic voltammetry, impedance spectroscopy, square wave voltammetry)
and other analytical techniques (dynamic light scattering, zeta potential and Brunauer–Emmett–Teller (BET)
surface area analysis) techniques.
The specific aptamers conjugated with enhanced nanostructures conferred both selectivity and
sensitivity in spiked water samples and complex matrices like juices and sera, with minor pre-processing steps
mentioned in respective chapters. The following biosensing platforms were demonstrated for the selected
targets:
(i)
Label-free impedimetric sensing of E. coli O78:H11 was successfully demonstrated using novel
selected aptamer functionalized bridged rebar graphene (synthesized by un-scrolling of multiwall carbon
nanotubes and bridged using terephthalaldehyde forming 3D nano-construct) onto disposable screen-printed
electrodes demonstrating a limit of detection ~ 10 cells and a dynamic response range from 10 1 to 10 6 cells.
(ii)
Label-free impedimetric sensing of E. coli O157:H7 was showed using specific aptamer
functionalized boron-carbon nanorods decorated by nickel nanoparticles with a similar limit of detection
and a dynamic detection range of 10 0 to 10 5 cells in water and juice samples.
(iii)
Fluorescence ‘turn on’ bioassay based on fluorescence quenching of aptamer functionalized carbon-
dots by silver nanoparticles, which in the presence of the E. coli O157:H7 purified O-antigen and H-antigen
was recovered, showing a limit of 0.12 pg mL -1 , a wide dynamic range of detection (1 pg mL -1 – 10 ng mL -1 )
and the stable response recorded even in pure water.
(iv)
A voltammetric diagnostic assay via aptamer functionalized onto chitosan exfoliated 2D tungsten
diselenide (WSe 2 ) nanosheet platform showing a dynamic response range from 50 pg mL -1 – 100 ng mL -1 , and
iidetection limit of 44.5 pg mL -1 & 41.3 pg mL -1 for Stx1 and Stx2, respectively, which showed minimal cross-
reactivity in spiked sera samples.
These nanostructured aptasensors showed quick results, negating the enrichment of bacterial load in
test samples as required in conventional systems. The aptamers also showed admirable application as capture
& detection for bacterial populations onto soft-lithographed polydimethylsiloxane based microfluidic
biosensing platforms.
In toto, this thesis addresses the issues of conventional detection of enteric pathogenic E. coli species
and, the unique detection methodologies presented in the studies can be further extended to other clinically or
environmentally relevant bacterial species, antigens or biomolecules, including viral diseases like COVID-19,
hepatitis, and influenza. The scientific works included herein are advantageous for the development of analytical
platforms using cost & reagent-effective protocols for pathogen or bio-analyte determination and thus, holds
promising future perspectives in the field of in-vitro clinical diagnostics.